MedTrace Logo

Evaluation of Rupture of Galenic Practices at Home in a Population Aged 65 or Older

NCT03681899 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 289

Last updated 2020-07-10

No results posted yet for this study

Summary

Elderly people frequently take several medications and are exposed to iatrogenic risks.

The oral route is the preferred route of administration. The effectiveness and the safety of the drugs depend in particular on the modes of administration (frequency of the intake, respect of the doses and the galenic ...).

However, these modalities are very little known concerning the treatments intake at home in the elderly population.

In a health facility welcoming geriatric patients, the rupture of galenic is frequent and favored by swallowing disorders, dependence, the increase in age, the presence of cognitive disorders or psycho-behavioral disorders.

The consequences of the rupture of galenic are numerous, concern the patients but also the caregivers who administer the treatments.

Conditions

  • Geriatric Assessment

Interventions

OTHER

Questionnaires

* Socio-demographic data (age, sex, place of residence, and family status, last occupation, existence or not of a primary caregiver (family and / or professional)); * Medical and surgical history (Charlson Comorbidity Scale); * Assessment of oral/dental condition * Record of drug treatments (number of oral medications per day, therapeutic class, number of daily intakes); * Oral treatments intake modalities (galenic breakdown of one or more drugs, usual or occasional, modalities of rupture, person responsible for the drugs, mixing with food / drink); * Autonomy evaluation (Lawton and Katz scales); * Mobility assessment (anamnestic evaluation); * Evaluation of Thyme (GDS 4 items); * Psycho-behavioral disorders, * Assessment of swallowing (presence of a diagnosis of dysphagia or suspicion based on anamnestic data).

Sponsors & Collaborators

  • University Hospital Center of Martinique

    lead OTHER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-18
Primary Completion
2019-12-18
Completion
2019-12-18

Countries

  • France

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03681899 on ClinicalTrials.gov